Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats

被引:41
|
作者
Miyata, M [1 ]
Ito, M [1 ]
Sasajima, T [1 ]
Ohira, H [1 ]
Kasukawa, R [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 2, Fukushima, Japan
关键词
5-hydroxytryptamine; interleukin; 6; MCI-90-42; pulmonary hypertension; serotonin; serotonin receptor; serotonin receptor antagonist; thromboembolic pulmonary hypertension;
D O I
10.1378/chest.119.2.554
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the significance of serotonin in the pathogenesis of interleukin (IL) 6-induced pulmonary hypertension (IL-6-PH) in rats, the plasma serotonin concentrations, and the effects of a specific antagonist of the serotonin (5-hydroxytryptamine [5-HT]) receptor, 1-[o-(m-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)-2-propyl hydrogen succinate hydrochloride (MCI) on the degree of pulmonary hypertension (PH) were investigated in MCI-treated IL-6-PH (IL-6-MCI-PH) rats. Measurements: The thickness of the media of small pulmonary arteries and the ratio of the weight of the right ventricle free wall (RV) to that of the left ventricle with the septum (LV + S) were measured as indexes of the degree of PH. Serotonin concentrations in plasma and in supernatants of cultured vascular smooth muscle cells (VSMCs) stimulated by IL-6 were measured by high-performance liquid chromatography. The amplification of DNA encoding the 5-HT receptor in the lung specimen and VSMCs was performed by polymerase chain reaction. Results: The degree of PH, as determined by the medial thickness of small pulmonary arteries, was significantly increased in IL-6-PH rats as compared with normal control rats (p < 0.05), and that in IL-6-MCI-PH rats was not significantly different from that in normal control rats. The RV/LV + S weight ratio in the IL-6-PH rats was significantly higher than that in normal control rats (p < 0.01). The RV/LV + S weight ratio in IL-6-MCI-PH rats was significantly lower than that in IL-6-PH rats (p < 0.01) and was not significantly different from that in normal control rats. The serotonin concentration was significantly higher in IL-6-PH rats than in normal control rats (p < 0.02), and the serotonin concentration in IL-6-MCI-PH rats was not significantly different from that in the normal control rats. The expression levels of the 5-HT receptor messenger RNA in the lung tissue tended to increase in IL-6-PH rats but was suppressed in IL-6-MCI-PH rats. IL-6 significantly increased the amount of serotonin released from VSMCs (p < 0.02). The expression of the 5-HT receptor messenger RNA was observed with IL-6 stimulation as was observed with serotonin stimulation in VSMCs. Conclusions: Serotonin receptor antagonists could be considered as potentially useful agents for the treatment of chronic thromboembolic PH, as well as for that of primary PH and PH associated with collagen vascular diseases.
引用
收藏
页码:554 / 561
页数:8
相关论文
共 50 条
  • [31] NANOG Dominates Interleukin-6-Induced Sphere Formation in Prostate Cancer
    Seven, Didem
    Tecimel, Didem
    Bayrak, Omer Faruk
    UROLOGY RESEARCH AND PRACTICE, 2023, 49 (06) : 376 - 380
  • [32] EFFECT OF ENDOTHELIN RECEPTOR ANTAGONIST ON CYCLOSPORINE-INDUCED HYPERTENSION
    TAKEDA, Y
    MIYAMORI, I
    WU, P
    HURUKAWA, K
    INABA, S
    ITO, Y
    TAKEDA, R
    MABUCHI, H
    HYPERTENSION, 1995, 25 (06) : 1362 - 1362
  • [33] Interleukin-6-induced thrombopoietin mediates inflammation-associated thrombocytosis
    Kaser, A
    Brandacher, G
    Steurer, W
    Kaser, S
    Offner, FA
    Molnar, C
    Atkins, MB
    Mier, JW
    Tilg, H
    GASTROENTEROLOGY, 2001, 120 (05) : A727 - A727
  • [34] Interleukin-6 in pulmonary hypertension
    Mathew, R
    Yuan, N
    Gewitz, MH
    CIRCULATION, 2000, 102 (18) : 330 - 330
  • [35] Serotonin receptor inhibition protects from pulmonary hypertension induced by RhoA inactivation
    Guilluy, C
    Boularan, C
    Loirand, G
    Pacaud, P
    CIRCULATION, 2004, 110 (17) : 132 - 132
  • [36] EFFECT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST ON ANTIGEN-INDUCED PULMONARY RESPONSES IN GUINEA-PIGS
    SELIG, W
    TOCKER, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (03) : 331 - 336
  • [37] Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation
    Wang, Qi
    Zhou, Ji-Long
    Wang, Hui
    Ju, Qiang
    Ding, Zhen
    Zhou, Xiao-Long
    Ge, Xing
    Shi, Qiao-Mei
    Pan, Chen
    Zhang, Jin-Peng
    Zhang, Mei-Rong
    Yu, Hong-Min
    Xu, Li-Chun
    CHEMOSPHERE, 2016, 158 : 24 - 29
  • [38] PULMONARY-HYPERTENSION IN RATS .2. ROLE OF INTERLEUKIN-6
    MIYATA, M
    SAKUMA, F
    YOSHIMURA, A
    ISHIKAWA, H
    NISHIMAKI, T
    KASUKAWA, R
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (03) : 287 - 291
  • [39] Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan
    Schroll, Stephan
    Arzt, Michael
    Sebah, Daniela
    Nuechterlein, Martin
    Blumberg, Friedrich
    Pfeifer, Michael
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 170 (01) : 32 - 36
  • [40] Analysis of interleukin-6-induced signaling in murine hybridoma cell lines
    Takemura, Kazuhiko
    Yamashita, Tatuya
    Terada, Satoshi
    ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 14, 2006, : 347 - +